1037 — Maxnerva Technology Services Income Statement
0.000.00%
- HK$160.65m
- -HK$37.15m
- CNY677.88m
- 47
- 76
- 33
- 52
Annual income statement for Maxnerva Technology Services, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 431 | 523 | 596 | 832 | 678 |
Cost of Revenue | |||||
Gross Profit | 77.2 | 94.3 | 114 | 127 | 96.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 417 | 503 | 560 | 800 | 689 |
Operating Profit | 13.8 | 20.9 | 36.1 | 32.4 | -11.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 14.8 | 22.4 | 37.6 | 30.5 | -14.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.6 | 14.6 | 34.3 | 27.8 | -16.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 11.6 | 14.6 | 34.3 | 27.8 | -16.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11.6 | 14.6 | 34.3 | 27.8 | -16.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.018 | 0.022 | 0.049 | 0.04 | -0.012 |